Knowledge Center
The New York State Department of Health issued guidance on the use of COVID-19 sick leave, which appears to expand the ability of individuals to access COVID-19 sick leave beyond the scope of the
For quarters beginning on and after January 1, 2020, CMS will require Responsible Reporting Entities (RREs) to include information on prescription drugs in their Section 111 quarterly reporting.
091019 California Relaxes Registration Requirements for Opposite-Sex Domestic Partners
In a bipartisan effort, the U.S. Congress agreed on a spending package to fund the federal government which included important changes to federal laws affecting employer-sponsored group health and
Guiding Employers Through Challenges in Employee Benefits
The Consolidated Appropriations Act, 2021 amends the Mental Health Parity and Addiction Equity Act of 2008 to require group health plans and health insurers to conduct a comparative analysis of
Although the severity and extent of the COVID-19 pandemic has been unprecedented in modern times, there are safeguards built into the structure of the insurance industry that are designed to maintain
Specialty drugs are expensive medications that are used to treat complex, chronic medical conditions. They are often given by injection or infusion and are potential life savers for patients
Recently, the term “transparency in healthcare” has been mentioned during discussions focusing on our nation’s healthcare system and ensuing conversation often centers on how the lack of transparency
The IRS has announced that amounts paid for certain personal protective equipment used to prevent the spread of COVID-19, including masks, hand sanitizer and sanitizing wipes can be treated as
Our Advisors offer in-depth analysis and are ready to help you successfully navigate employee benefits and health insurance.
Our website uses cookies. Click here to view our privacy policy.